Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples